Search results

Page results

• Haematology Life magazine

  Latest issues of our Haematology Life magazine

• Resident Doctor's Workshops (2024)

  Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the well being of doctors.

• International Day of Women and Girls in Science – focus on proton beam therapy

  Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.

• UCLH doctor 1 of 10 international members elected to National Academy of Medicine

  UCLH doctor 1 of 10 international members elected to National Academy of Medicine

• Recruitment milestone reached in large breast cancer trial

  3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.

• UCLH recruits first participant internationally for new trial in Frontotemporal dementia

  UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.

• Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

  Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.

• UCLH doctors take part in art workshops

  Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.

• Immunomodulatory drug for COVID-19 trialled at UCLH

  UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).

• NHS patients to benefit from state-of-the-art diagnostic tests for Parkinson’s & Mitochondrial diseases, resulting from a UK-first partnership

  Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).